J. Larkin, V. Chiarion-sileni, and R. Gonzalez, Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma, New England Journal of Medicine, vol.373, issue.1, pp.23-34, 2015.
DOI : 10.1056/NEJMoa1504030

P. Chapman, A. Hauschild, and C. Robert, Improved survival with vemurafenib in melanoma with BRAF V600E mutation Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations, N Engl J Med N Engl J Med, vol.364367, issue.2618, pp.2507-2523, 2011.

S. Russell, K. Peng, J. Bell, H. Kaufman, F. Kohlhapp et al., Oncolytic virotherapy Oncolytic viruses: a new class of immunotherapy drugs Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma, Nat Biotechnol Nat Rev Drug Discov J Clin Oncol, vol.301433, issue.7925, pp.658-70, 2012.

P. Msaouel, I. Iankov, A. Dispenzieri, and E. Galanis, Attenuated Oncolytic Measles Virus Strains as Cancer Therapeutics, Current Pharmaceutical Biotechnology, vol.13, issue.9, pp.1732-1773, 2012.
DOI : 10.2174/138920112800958896
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298624

E. Galanis, P. Atherton, and M. Maurer, Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer, Cancer Research, vol.75, issue.1, pp.22-30, 2015.
DOI : 10.1158/0008-5472.CAN-14-2533

S. Russell, M. Federspiel, and K. Peng, Remission of disseminated cancer after systemic oncolytic virotherapy The human CD46 molecule is a receptor for measles virus (Edmonston strain) High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus, Mayo Clin Proc Cell Cancer Res, vol.891175126413, issue.7214, pp.926-959, 1993.

C. Achard, N. Boisgerault, and T. Delaunay, Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virusbased oncolysis, Oncotarget J Virol, vol.6148715, issue.426, pp.44892-904, 2013.

M. Patel, B. Jacobson, and H. Belgum, Measles Vaccine Strains for Virotherapy of Non???Small-Cell Lung Carcinoma, Journal of Thoracic Oncology, vol.9, issue.8, pp.1101-1111, 2014.
DOI : 10.1097/JTO.0000000000000214

K. Parato, C. Breitbach, L. Boeuf, and F. , The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers Evaluation of an attenuated vesicular stomatitis virus vector expressing interferon-beta for use in malignant pleural mesothelioma: heterogeneity in interferon responsiveness defines potential efficacy, Mol Ther Hum Gene Ther, vol.201721, issue.41, pp.749-58, 2010.

S. Ikegame, M. Takeda, S. Ohno, Y. Nakatsu, Y. Nakanishi et al., Both RIG-I and MDA5 RNA Helicases Contribute to the Induction of Alpha/Beta Interferon in Measles Virus-Infected Human Cells, Journal of Virology, vol.84, issue.1, pp.372-381, 2010.
DOI : 10.1128/JVI.01690-09

H. Kato, O. Takeuchi, and S. Sato, Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses Measles virus causes immunogenic cell death in human melanoma, Nature Gene Ther, vol.441202021, issue.70891, pp.101-106, 2006.

C. Combredet, V. Labrousse, and L. Mollet, A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic Mice, Journal of Virology, vol.77, issue.21, pp.11546-54, 2003.
DOI : 10.1128/JVI.77.21.11546-11554.2003

J. Schindelin, I. Arganda-carreras, and E. Frise, Fiji: an opensource platform for biological-image analysis The prevalence of interferon-alpha transcription defects in malignant melanoma Measles virus induces oncolysis of mesothelioma cells and allows dendritic cells to cross-prime tumor-specific CD8 response, Nat Methods Melanoma Res Cancer Res, vol.923156825, issue.7212, pp.676-82, 2005.

J. Guillerme, N. Boisgerault, and D. Roulois, Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells, Clinical Cancer Research, vol.19, issue.5, pp.1147-58, 2013.
DOI : 10.1158/1078-0432.CCR-12-2733